secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2023-01-23T23:59:59+00:00
Accession:  0001493152-23-002194
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics completes 1-for-60 reverse stock split to maintain NYSE American listing
--------------------------------------------------------------------------------

- Reverse stock split effective 5:00 p.m. EST on Jan 20, 2023; shares began trading split-adjusted Jan 23.
- Authorized shares reduced from 250M to ~4.17M; outstanding from ~117.66M to ~1.96M post-split.
- No fractional shares issued; any fractional interest rounded up to one whole share.
- Split approved solely by Board under Florida law, no shareholder vote required.
- Reason: to meet NYSE American continued listing standards and reduce risk of delisting due to low stock price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315223002194/0001493152-23-002194-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315223002194/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-002194

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer